Pulmonary administration of remdesivir in the treatment of COVID-19
- PMID: 32944838
- PMCID: PMC7498113
- DOI: 10.1208/s12248-020-00506-4
Pulmonary administration of remdesivir in the treatment of COVID-19
Comment on
-
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.AAPS J. 2020 May 26;22(4):77. doi: 10.1208/s12248-020-00459-8. AAPS J. 2020. PMID: 32458279 Free PMC article.
References
-
- Buss N, Cammack N. Measuring the effectiveness of antiretroviral agents. Antivir Ther. 2001;6:1–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources